nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—attention deficit hyperactivity disorder—Clonidine—glaucoma	0.5	1	CpDpCtD
Modafinil—ADRA1B—Clonidine—glaucoma	0.0494	0.162	CbGbCtD
Modafinil—CYP1A2—Betaxolol—glaucoma	0.03	0.0981	CbGbCtD
Modafinil—CYP2C19—Methazolamide—glaucoma	0.0246	0.0806	CbGbCtD
Modafinil—CYP2C9—Diclofenamide—glaucoma	0.0238	0.0778	CbGbCtD
Modafinil—CYP2C9—Dorzolamide—glaucoma	0.023	0.0752	CbGbCtD
Modafinil—CYP3A5—Clonidine—glaucoma	0.0221	0.0722	CbGbCtD
Modafinil—CYP2C19—Timolol—glaucoma	0.0209	0.0685	CbGbCtD
Modafinil—CYP2C9—Methazolamide—glaucoma	0.0205	0.067	CbGbCtD
Modafinil—CYP3A4—Pilocarpine—glaucoma	0.0176	0.0577	CbGbCtD
Modafinil—CYP1A2—Clonidine—glaucoma	0.0164	0.0538	CbGbCtD
Modafinil—CYP3A4—Brinzolamide—glaucoma	0.0138	0.0453	CbGbCtD
Modafinil—CYP3A4—Dorzolamide—glaucoma	0.0133	0.0437	CbGbCtD
Modafinil—CYP3A4—Methazolamide—glaucoma	0.0119	0.039	CbGbCtD
Modafinil—CYP3A4—Acetazolamide—glaucoma	0.00951	0.0311	CbGbCtD
Modafinil—CYP3A4—Clonidine—glaucoma	0.0086	0.0282	CbGbCtD
Modafinil—Nepafenac—PTGS2—glaucoma	0.000155	0.288	CrCbGaD
Modafinil—Oxaprozin—PTGS2—glaucoma	0.000129	0.239	CrCbGaD
Modafinil—Fenoprofen—PTGS2—glaucoma	0.000107	0.198	CrCbGaD
Modafinil—Feeling abnormal—Dorzolamide—glaucoma	0.000102	0.00057	CcSEcCtD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000102	0.00682	CbGpPWpGaD
Modafinil—Decreased appetite—Pilocarpine—glaucoma	0.000102	0.000568	CcSEcCtD
Modafinil—Feeling abnormal—Travoprost—glaucoma	0.000102	0.000568	CcSEcCtD
Modafinil—Conjunctivitis—Timolol—glaucoma	0.000101	0.000566	CcSEcCtD
Modafinil—Gastrointestinal pain—Dorzolamide—glaucoma	0.000101	0.000566	CcSEcCtD
Modafinil—Palpitations—Clonidine—glaucoma	0.000101	0.000565	CcSEcCtD
Modafinil—SLC6A3—NRF2 pathway—TXN—glaucoma	0.000101	0.00676	CbGpPWpGaD
Modafinil—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000101	0.000564	CcSEcCtD
Modafinil—Gastrointestinal pain—Travoprost—glaucoma	0.000101	0.000563	CcSEcCtD
Modafinil—Loss of consciousness—Clonidine—glaucoma	0.000101	0.000562	CcSEcCtD
Modafinil—Feeling abnormal—Brinzolamide—glaucoma	0.0001	0.00056	CcSEcCtD
Modafinil—Mental disorder—Betaxolol—glaucoma	0.0001	0.00056	CcSEcCtD
Modafinil—Constipation—Pilocarpine—glaucoma	0.0001	0.000559	CcSEcCtD
Modafinil—Pain—Pilocarpine—glaucoma	0.0001	0.000559	CcSEcCtD
Modafinil—Cough—Clonidine—glaucoma	9.99e-05	0.000558	CcSEcCtD
Modafinil—Sweating—Timolol—glaucoma	9.99e-05	0.000558	CcSEcCtD
Modafinil—Dizziness—Apraclonidine—glaucoma	9.99e-05	0.000558	CcSEcCtD
Modafinil—Malnutrition—Betaxolol—glaucoma	9.97e-05	0.000557	CcSEcCtD
Modafinil—Urticaria—Dorzolamide—glaucoma	9.84e-05	0.00055	CcSEcCtD
Modafinil—Epistaxis—Timolol—glaucoma	9.83e-05	0.000549	CcSEcCtD
Modafinil—Abdominal pain—Dorzolamide—glaucoma	9.79e-05	0.000547	CcSEcCtD
Modafinil—Body temperature increased—Dorzolamide—glaucoma	9.79e-05	0.000547	CcSEcCtD
Modafinil—Tension—Betaxolol—glaucoma	9.78e-05	0.000546	CcSEcCtD
Modafinil—Sinusitis—Timolol—glaucoma	9.78e-05	0.000546	CcSEcCtD
Modafinil—Dysgeusia—Betaxolol—glaucoma	9.76e-05	0.000545	CcSEcCtD
Modafinil—Arthralgia—Clonidine—glaucoma	9.75e-05	0.000545	CcSEcCtD
Modafinil—Chest pain—Clonidine—glaucoma	9.75e-05	0.000545	CcSEcCtD
Modafinil—Abdominal pain—Travoprost—glaucoma	9.75e-05	0.000544	CcSEcCtD
Modafinil—Agranulocytosis—Timolol—glaucoma	9.73e-05	0.000543	CcSEcCtD
Modafinil—Anxiety—Clonidine—glaucoma	9.72e-05	0.000543	CcSEcCtD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	9.71e-05	0.0065	CbGpPWpGaD
Modafinil—Asthenia—Acetazolamide—glaucoma	9.7e-05	0.000541	CcSEcCtD
Modafinil—Dizziness—Bimatoprost—glaucoma	9.69e-05	0.000541	CcSEcCtD
Modafinil—Nervousness—Betaxolol—glaucoma	9.68e-05	0.000541	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	9.68e-05	0.000541	CcSEcCtD
Modafinil—Urticaria—Brinzolamide—glaucoma	9.67e-05	0.00054	CcSEcCtD
Modafinil—Feeling abnormal—Pilocarpine—glaucoma	9.65e-05	0.000539	CcSEcCtD
Modafinil—Discomfort—Clonidine—glaucoma	9.63e-05	0.000538	CcSEcCtD
Modafinil—Vomiting—Apraclonidine—glaucoma	9.61e-05	0.000536	CcSEcCtD
Modafinil—Muscle spasms—Betaxolol—glaucoma	9.59e-05	0.000535	CcSEcCtD
Modafinil—SLC6A3—Transmission across Chemical Synapses—SLC6A13—glaucoma	9.57e-05	0.0064	CbGpPWpGaD
Modafinil—Gastrointestinal pain—Pilocarpine—glaucoma	9.57e-05	0.000535	CcSEcCtD
Modafinil—Hypersensitivity—Brimonidine—glaucoma	9.56e-05	0.000534	CcSEcCtD
Modafinil—Dry mouth—Clonidine—glaucoma	9.54e-05	0.000533	CcSEcCtD
Modafinil—Bradycardia—Timolol—glaucoma	9.53e-05	0.000532	CcSEcCtD
Modafinil—Dermatitis—Apraclonidine—glaucoma	9.52e-05	0.000531	CcSEcCtD
Modafinil—Headache—Apraclonidine—glaucoma	9.46e-05	0.000529	CcSEcCtD
Modafinil—Confusional state—Clonidine—glaucoma	9.42e-05	0.000526	CcSEcCtD
Modafinil—Rhinitis—Timolol—glaucoma	9.38e-05	0.000524	CcSEcCtD
Modafinil—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	9.38e-05	0.00627	CbGpPWpGaD
Modafinil—Oedema—Clonidine—glaucoma	9.35e-05	0.000522	CcSEcCtD
Modafinil—Tremor—Betaxolol—glaucoma	9.34e-05	0.000522	CcSEcCtD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	9.33e-05	0.00624	CbGpPWpGaD
Modafinil—Hallucination—Timolol—glaucoma	9.31e-05	0.00052	CcSEcCtD
Modafinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	9.31e-05	0.00623	CbGpPWpGaD
Modafinil—Asthenia—Brimonidine—glaucoma	9.31e-05	0.00052	CcSEcCtD
Modafinil—Infection—Clonidine—glaucoma	9.29e-05	0.000519	CcSEcCtD
Modafinil—Abdominal pain—Pilocarpine—glaucoma	9.25e-05	0.000517	CcSEcCtD
Modafinil—Body temperature increased—Pilocarpine—glaucoma	9.25e-05	0.000517	CcSEcCtD
Modafinil—Ill-defined disorder—Betaxolol—glaucoma	9.25e-05	0.000517	CcSEcCtD
Modafinil—Diarrhoea—Acetazolamide—glaucoma	9.25e-05	0.000516	CcSEcCtD
Modafinil—Rash—Bimatoprost—glaucoma	9.24e-05	0.000516	CcSEcCtD
Modafinil—Dermatitis—Bimatoprost—glaucoma	9.23e-05	0.000515	CcSEcCtD
Modafinil—Oedema peripheral—Timolol—glaucoma	9.22e-05	0.000515	CcSEcCtD
Modafinil—Anaemia—Betaxolol—glaucoma	9.22e-05	0.000515	CcSEcCtD
Modafinil—Shock—Clonidine—glaucoma	9.2e-05	0.000514	CcSEcCtD
Modafinil—Connective tissue disorder—Timolol—glaucoma	9.19e-05	0.000514	CcSEcCtD
Modafinil—Pruritus—Brimonidine—glaucoma	9.18e-05	0.000512	CcSEcCtD
Modafinil—Headache—Bimatoprost—glaucoma	9.18e-05	0.000512	CcSEcCtD
Modafinil—Nervous system disorder—Clonidine—glaucoma	9.17e-05	0.000512	CcSEcCtD
Modafinil—Hypersensitivity—Dorzolamide—glaucoma	9.13e-05	0.00051	CcSEcCtD
Modafinil—Tachycardia—Clonidine—glaucoma	9.12e-05	0.000509	CcSEcCtD
Modafinil—Hypersensitivity—Travoprost—glaucoma	9.09e-05	0.000507	CcSEcCtD
Modafinil—Skin disorder—Clonidine—glaucoma	9.08e-05	0.000507	CcSEcCtD
Modafinil—Hyperhidrosis—Clonidine—glaucoma	9.04e-05	0.000505	CcSEcCtD
Modafinil—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	9.04e-05	0.00604	CbGpPWpGaD
Modafinil—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	9.03e-05	0.00604	CbGpPWpGaD
Modafinil—Visual impairment—Timolol—glaucoma	9.02e-05	0.000504	CcSEcCtD
Modafinil—SLC6A3—NRF2 pathway—SLC6A1—glaucoma	9.01e-05	0.00603	CbGpPWpGaD
Modafinil—Malaise—Betaxolol—glaucoma	8.99e-05	0.000502	CcSEcCtD
Modafinil—Nausea—Apraclonidine—glaucoma	8.97e-05	0.000501	CcSEcCtD
Modafinil—Hypersensitivity—Brinzolamide—glaucoma	8.97e-05	0.000501	CcSEcCtD
Modafinil—Vertigo—Betaxolol—glaucoma	8.96e-05	0.0005	CcSEcCtD
Modafinil—Syncope—Betaxolol—glaucoma	8.94e-05	0.000499	CcSEcCtD
Modafinil—Dizziness—Acetazolamide—glaucoma	8.94e-05	0.000499	CcSEcCtD
Modafinil—Anorexia—Clonidine—glaucoma	8.91e-05	0.000498	CcSEcCtD
Modafinil—Asthenia—Dorzolamide—glaucoma	8.89e-05	0.000496	CcSEcCtD
Modafinil—Asthenia—Travoprost—glaucoma	8.85e-05	0.000494	CcSEcCtD
Modafinil—Palpitations—Betaxolol—glaucoma	8.81e-05	0.000492	CcSEcCtD
Modafinil—Pruritus—Dorzolamide—glaucoma	8.76e-05	0.000489	CcSEcCtD
Modafinil—Loss of consciousness—Betaxolol—glaucoma	8.76e-05	0.000489	CcSEcCtD
Modafinil—SLC6A3—Transmembrane transport of small molecules—PEX19—glaucoma	8.75e-05	0.00585	CbGpPWpGaD
Modafinil—Asthenia—Brinzolamide—glaucoma	8.74e-05	0.000488	CcSEcCtD
Modafinil—Hypotension—Clonidine—glaucoma	8.73e-05	0.000488	CcSEcCtD
Modafinil—Pruritus—Travoprost—glaucoma	8.73e-05	0.000487	CcSEcCtD
Modafinil—Cough—Betaxolol—glaucoma	8.7e-05	0.000486	CcSEcCtD
Modafinil—Nausea—Bimatoprost—glaucoma	8.7e-05	0.000486	CcSEcCtD
Modafinil—Cardiac disorder—Timolol—glaucoma	8.68e-05	0.000485	CcSEcCtD
Modafinil—Hypersensitivity—Pilocarpine—glaucoma	8.62e-05	0.000482	CcSEcCtD
Modafinil—Pruritus—Brinzolamide—glaucoma	8.62e-05	0.000481	CcSEcCtD
Modafinil—Vomiting—Acetazolamide—glaucoma	8.59e-05	0.00048	CcSEcCtD
Modafinil—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.58e-05	0.00574	CbGpPWpGaD
Modafinil—Dizziness—Brimonidine—glaucoma	8.58e-05	0.000479	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—glaucoma	8.54e-05	0.158	CrCbGaD
Modafinil—Musculoskeletal discomfort—Clonidine—glaucoma	8.52e-05	0.000476	CcSEcCtD
Modafinil—Angiopathy—Timolol—glaucoma	8.49e-05	0.000474	CcSEcCtD
Modafinil—Chest pain—Betaxolol—glaucoma	8.49e-05	0.000474	CcSEcCtD
Modafinil—Arthralgia—Betaxolol—glaucoma	8.49e-05	0.000474	CcSEcCtD
Modafinil—Myalgia—Betaxolol—glaucoma	8.49e-05	0.000474	CcSEcCtD
Modafinil—Diarrhoea—Dorzolamide—glaucoma	8.48e-05	0.000473	CcSEcCtD
Modafinil—Headache—Acetazolamide—glaucoma	8.47e-05	0.000473	CcSEcCtD
Modafinil—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.46e-05	0.00566	CbGpPWpGaD
Modafinil—Anxiety—Betaxolol—glaucoma	8.46e-05	0.000472	CcSEcCtD
Modafinil—Insomnia—Clonidine—glaucoma	8.45e-05	0.000472	CcSEcCtD
Modafinil—Immune system disorder—Timolol—glaucoma	8.45e-05	0.000472	CcSEcCtD
Modafinil—Diarrhoea—Travoprost—glaucoma	8.44e-05	0.000471	CcSEcCtD
Modafinil—Mediastinal disorder—Timolol—glaucoma	8.43e-05	0.000471	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	8.43e-05	0.000471	CcSEcCtD
Modafinil—Asthenia—Pilocarpine—glaucoma	8.4e-05	0.000469	CcSEcCtD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	8.4e-05	0.00562	CbGpPWpGaD
Modafinil—Paraesthesia—Clonidine—glaucoma	8.39e-05	0.000469	CcSEcCtD
Modafinil—Discomfort—Betaxolol—glaucoma	8.39e-05	0.000468	CcSEcCtD
Modafinil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.38e-05	0.00561	CbGpPWpGaD
Modafinil—Arrhythmia—Timolol—glaucoma	8.36e-05	0.000467	CcSEcCtD
Modafinil—Dyspnoea—Clonidine—glaucoma	8.33e-05	0.000465	CcSEcCtD
Modafinil—Diarrhoea—Brinzolamide—glaucoma	8.33e-05	0.000465	CcSEcCtD
Modafinil—Somnolence—Clonidine—glaucoma	8.31e-05	0.000464	CcSEcCtD
Modafinil—Dry mouth—Betaxolol—glaucoma	8.3e-05	0.000464	CcSEcCtD
Modafinil—Pruritus—Pilocarpine—glaucoma	8.28e-05	0.000462	CcSEcCtD
Modafinil—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.27e-05	0.00553	CbGpPWpGaD
Modafinil—Confusional state—Betaxolol—glaucoma	8.21e-05	0.000458	CcSEcCtD
Modafinil—Mental disorder—Timolol—glaucoma	8.2e-05	0.000458	CcSEcCtD
Modafinil—Dizziness—Dorzolamide—glaucoma	8.19e-05	0.000457	CcSEcCtD
Modafinil—Rash—Brimonidine—glaucoma	8.18e-05	0.000457	CcSEcCtD
Modafinil—Dermatitis—Brimonidine—glaucoma	8.17e-05	0.000456	CcSEcCtD
Modafinil—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	8.16e-05	0.00546	CbGpPWpGaD
Modafinil—Dizziness—Travoprost—glaucoma	8.16e-05	0.000455	CcSEcCtD
Modafinil—Malnutrition—Timolol—glaucoma	8.15e-05	0.000455	CcSEcCtD
Modafinil—Oedema—Betaxolol—glaucoma	8.14e-05	0.000454	CcSEcCtD
Modafinil—Headache—Brimonidine—glaucoma	8.13e-05	0.000454	CcSEcCtD
Modafinil—Decreased appetite—Clonidine—glaucoma	8.13e-05	0.000454	CcSEcCtD
Modafinil—Infection—Betaxolol—glaucoma	8.08e-05	0.000451	CcSEcCtD
Modafinil—Gastrointestinal disorder—Clonidine—glaucoma	8.07e-05	0.000451	CcSEcCtD
Modafinil—Fatigue—Clonidine—glaucoma	8.06e-05	0.00045	CcSEcCtD
Modafinil—Dizziness—Brinzolamide—glaucoma	8.05e-05	0.00045	CcSEcCtD
Modafinil—Nausea—Acetazolamide—glaucoma	8.03e-05	0.000448	CcSEcCtD
Modafinil—Diarrhoea—Pilocarpine—glaucoma	8.01e-05	0.000447	CcSEcCtD
Modafinil—Shock—Betaxolol—glaucoma	8.01e-05	0.000447	CcSEcCtD
Modafinil—Tension—Timolol—glaucoma	7.99e-05	0.000446	CcSEcCtD
Modafinil—Pain—Clonidine—glaucoma	7.99e-05	0.000446	CcSEcCtD
Modafinil—Constipation—Clonidine—glaucoma	7.99e-05	0.000446	CcSEcCtD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	7.99e-05	0.00534	CbGpPWpGaD
Modafinil—Nervous system disorder—Betaxolol—glaucoma	7.98e-05	0.000446	CcSEcCtD
Modafinil—Dysgeusia—Timolol—glaucoma	7.98e-05	0.000445	CcSEcCtD
Modafinil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.96e-05	0.00532	CbGpPWpGaD
Modafinil—Tachycardia—Betaxolol—glaucoma	7.94e-05	0.000444	CcSEcCtD
Modafinil—Nervousness—Timolol—glaucoma	7.91e-05	0.000442	CcSEcCtD
Modafinil—Skin disorder—Betaxolol—glaucoma	7.9e-05	0.000441	CcSEcCtD
Modafinil—Vomiting—Dorzolamide—glaucoma	7.88e-05	0.00044	CcSEcCtD
Modafinil—Hyperhidrosis—Betaxolol—glaucoma	7.87e-05	0.000439	CcSEcCtD
Modafinil—Rash—Dorzolamide—glaucoma	7.81e-05	0.000436	CcSEcCtD
Modafinil—Dermatitis—Dorzolamide—glaucoma	7.8e-05	0.000436	CcSEcCtD
Modafinil—Rash—Travoprost—glaucoma	7.78e-05	0.000434	CcSEcCtD
Modafinil—Dermatitis—Travoprost—glaucoma	7.77e-05	0.000434	CcSEcCtD
Modafinil—SLC6A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	7.76e-05	0.00519	CbGpPWpGaD
Modafinil—Headache—Dorzolamide—glaucoma	7.76e-05	0.000433	CcSEcCtD
Modafinil—Anorexia—Betaxolol—glaucoma	7.76e-05	0.000433	CcSEcCtD
Modafinil—Vomiting—Brinzolamide—glaucoma	7.74e-05	0.000432	CcSEcCtD
Modafinil—Dizziness—Pilocarpine—glaucoma	7.74e-05	0.000432	CcSEcCtD
Modafinil—Headache—Travoprost—glaucoma	7.73e-05	0.000431	CcSEcCtD
Modafinil—Nausea—Brimonidine—glaucoma	7.7e-05	0.00043	CcSEcCtD
Modafinil—Feeling abnormal—Clonidine—glaucoma	7.7e-05	0.00043	CcSEcCtD
Modafinil—Rash—Brinzolamide—glaucoma	7.68e-05	0.000429	CcSEcCtD
Modafinil—Dermatitis—Brinzolamide—glaucoma	7.67e-05	0.000428	CcSEcCtD
Modafinil—Gastrointestinal pain—Clonidine—glaucoma	7.64e-05	0.000427	CcSEcCtD
Modafinil—Headache—Brinzolamide—glaucoma	7.63e-05	0.000426	CcSEcCtD
Modafinil—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	7.63e-05	0.0051	CbGpPWpGaD
Modafinil—Hypotension—Betaxolol—glaucoma	7.6e-05	0.000425	CcSEcCtD
Modafinil—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	7.5e-05	0.00502	CbGpPWpGaD
Modafinil—Angioedema—Timolol—glaucoma	7.44e-05	0.000416	CcSEcCtD
Modafinil—Vomiting—Pilocarpine—glaucoma	7.44e-05	0.000416	CcSEcCtD
Modafinil—Urticaria—Clonidine—glaucoma	7.43e-05	0.000415	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Betaxolol—glaucoma	7.41e-05	0.000414	CcSEcCtD
Modafinil—Body temperature increased—Clonidine—glaucoma	7.39e-05	0.000413	CcSEcCtD
Modafinil—Abdominal pain—Clonidine—glaucoma	7.39e-05	0.000413	CcSEcCtD
Modafinil—Rash—Pilocarpine—glaucoma	7.38e-05	0.000412	CcSEcCtD
Modafinil—Dermatitis—Pilocarpine—glaucoma	7.37e-05	0.000412	CcSEcCtD
Modafinil—Insomnia—Betaxolol—glaucoma	7.36e-05	0.000411	CcSEcCtD
Modafinil—Nausea—Dorzolamide—glaucoma	7.36e-05	0.000411	CcSEcCtD
Modafinil—SLC6A3—NRF2 pathway—TGFB2—glaucoma	7.35e-05	0.00491	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—SLC6A13—glaucoma	7.34e-05	0.00491	CbGpPWpGaD
Modafinil—Headache—Pilocarpine—glaucoma	7.33e-05	0.000409	CcSEcCtD
Modafinil—Nausea—Travoprost—glaucoma	7.33e-05	0.000409	CcSEcCtD
Modafinil—Vertigo—Timolol—glaucoma	7.32e-05	0.000409	CcSEcCtD
Modafinil—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	7.31e-05	0.00489	CbGpPWpGaD
Modafinil—Paraesthesia—Betaxolol—glaucoma	7.31e-05	0.000408	CcSEcCtD
Modafinil—Syncope—Timolol—glaucoma	7.3e-05	0.000408	CcSEcCtD
Modafinil—Dyspnoea—Betaxolol—glaucoma	7.25e-05	0.000405	CcSEcCtD
Modafinil—Nausea—Brinzolamide—glaucoma	7.23e-05	0.000404	CcSEcCtD
Modafinil—Palpitations—Timolol—glaucoma	7.2e-05	0.000402	CcSEcCtD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	7.19e-05	0.00481	CbGpPWpGaD
Modafinil—Dyspepsia—Betaxolol—glaucoma	7.16e-05	0.0004	CcSEcCtD
Modafinil—Loss of consciousness—Timolol—glaucoma	7.16e-05	0.0004	CcSEcCtD
Modafinil—Cough—Timolol—glaucoma	7.11e-05	0.000397	CcSEcCtD
Modafinil—Decreased appetite—Betaxolol—glaucoma	7.07e-05	0.000395	CcSEcCtD
Modafinil—Hypertension—Timolol—glaucoma	7.03e-05	0.000393	CcSEcCtD
Modafinil—Gastrointestinal disorder—Betaxolol—glaucoma	7.03e-05	0.000392	CcSEcCtD
Modafinil—Fatigue—Betaxolol—glaucoma	7.02e-05	0.000392	CcSEcCtD
Modafinil—SLC6A3—Transmission across Chemical Synapses—SLC6A1—glaucoma	7.01e-05	0.00469	CbGpPWpGaD
Modafinil—Pain—Betaxolol—glaucoma	6.96e-05	0.000389	CcSEcCtD
Modafinil—Constipation—Betaxolol—glaucoma	6.96e-05	0.000389	CcSEcCtD
Modafinil—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.95e-05	0.00465	CbGpPWpGaD
Modafinil—Nausea—Pilocarpine—glaucoma	6.95e-05	0.000388	CcSEcCtD
Modafinil—Chest pain—Timolol—glaucoma	6.93e-05	0.000387	CcSEcCtD
Modafinil—Arthralgia—Timolol—glaucoma	6.93e-05	0.000387	CcSEcCtD
Modafinil—Myalgia—Timolol—glaucoma	6.93e-05	0.000387	CcSEcCtD
Modafinil—Anxiety—Timolol—glaucoma	6.91e-05	0.000386	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	6.89e-05	0.000385	CcSEcCtD
Modafinil—Hypersensitivity—Clonidine—glaucoma	6.89e-05	0.000385	CcSEcCtD
Modafinil—Discomfort—Timolol—glaucoma	6.85e-05	0.000383	CcSEcCtD
Modafinil—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	6.84e-05	0.00457	CbGpPWpGaD
Modafinil—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.8e-05	0.00455	CbGpPWpGaD
Modafinil—Dry mouth—Timolol—glaucoma	6.78e-05	0.000379	CcSEcCtD
Modafinil—Asthenia—Clonidine—glaucoma	6.71e-05	0.000375	CcSEcCtD
Modafinil—Feeling abnormal—Betaxolol—glaucoma	6.71e-05	0.000374	CcSEcCtD
Modafinil—Confusional state—Timolol—glaucoma	6.7e-05	0.000374	CcSEcCtD
Modafinil—Anaphylactic shock—Timolol—glaucoma	6.65e-05	0.000371	CcSEcCtD
Modafinil—Oedema—Timolol—glaucoma	6.65e-05	0.000371	CcSEcCtD
Modafinil—Pruritus—Clonidine—glaucoma	6.61e-05	0.000369	CcSEcCtD
Modafinil—Infection—Timolol—glaucoma	6.6e-05	0.000369	CcSEcCtD
Modafinil—Shock—Timolol—glaucoma	6.54e-05	0.000365	CcSEcCtD
Modafinil—Nervous system disorder—Timolol—glaucoma	6.52e-05	0.000364	CcSEcCtD
Modafinil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.48e-05	0.00433	CbGpPWpGaD
Modafinil—Urticaria—Betaxolol—glaucoma	6.46e-05	0.000361	CcSEcCtD
Modafinil—Skin disorder—Timolol—glaucoma	6.46e-05	0.000361	CcSEcCtD
Modafinil—Body temperature increased—Betaxolol—glaucoma	6.43e-05	0.000359	CcSEcCtD
Modafinil—Hyperhidrosis—Timolol—glaucoma	6.43e-05	0.000359	CcSEcCtD
Modafinil—SLC6A3—Monoamine Transport—TNF—glaucoma	6.4e-05	0.00428	CbGpPWpGaD
Modafinil—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.4e-05	0.00428	CbGpPWpGaD
Modafinil—Diarrhoea—Clonidine—glaucoma	6.4e-05	0.000357	CcSEcCtD
Modafinil—Anorexia—Timolol—glaucoma	6.34e-05	0.000354	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—glaucoma	6.3e-05	0.117	CrCbGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	6.25e-05	0.00418	CbGpPWpGaD
Modafinil—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	6.25e-05	0.00418	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	6.25e-05	0.00418	CbGpPWpGaD
Modafinil—Hypotension—Timolol—glaucoma	6.21e-05	0.000347	CcSEcCtD
Modafinil—Dizziness—Clonidine—glaucoma	6.18e-05	0.000345	CcSEcCtD
Modafinil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	6.14e-05	0.00411	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—OPN4—glaucoma	6.08e-05	0.00407	CbGpPWpGaD
Modafinil—Musculoskeletal discomfort—Timolol—glaucoma	6.06e-05	0.000338	CcSEcCtD
Modafinil—Insomnia—Timolol—glaucoma	6.01e-05	0.000336	CcSEcCtD
Modafinil—Hypersensitivity—Betaxolol—glaucoma	6e-05	0.000335	CcSEcCtD
Modafinil—Paraesthesia—Timolol—glaucoma	5.97e-05	0.000333	CcSEcCtD
Modafinil—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	5.94e-05	0.00397	CbGpPWpGaD
Modafinil—Vomiting—Clonidine—glaucoma	5.94e-05	0.000332	CcSEcCtD
Modafinil—Dyspnoea—Timolol—glaucoma	5.93e-05	0.000331	CcSEcCtD
Modafinil—SLC6A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.91e-05	0.00395	CbGpPWpGaD
Modafinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.91e-05	0.00395	CbGpPWpGaD
Modafinil—Somnolence—Timolol—glaucoma	5.91e-05	0.00033	CcSEcCtD
Modafinil—Rash—Clonidine—glaucoma	5.89e-05	0.000329	CcSEcCtD
Modafinil—Dermatitis—Clonidine—glaucoma	5.89e-05	0.000329	CcSEcCtD
Modafinil—Headache—Clonidine—glaucoma	5.86e-05	0.000327	CcSEcCtD
Modafinil—Dyspepsia—Timolol—glaucoma	5.85e-05	0.000327	CcSEcCtD
Modafinil—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	5.84e-05	0.00391	CbGpPWpGaD
Modafinil—Asthenia—Betaxolol—glaucoma	5.84e-05	0.000326	CcSEcCtD
Modafinil—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.83e-05	0.0039	CbGpPWpGaD
Modafinil—Decreased appetite—Timolol—glaucoma	5.78e-05	0.000323	CcSEcCtD
Modafinil—Pruritus—Betaxolol—glaucoma	5.76e-05	0.000322	CcSEcCtD
Modafinil—Gastrointestinal disorder—Timolol—glaucoma	5.74e-05	0.000321	CcSEcCtD
Modafinil—Fatigue—Timolol—glaucoma	5.73e-05	0.00032	CcSEcCtD
Modafinil—Pain—Timolol—glaucoma	5.68e-05	0.000317	CcSEcCtD
Modafinil—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	5.68e-05	0.0038	CbGpPWpGaD
Modafinil—Diarrhoea—Betaxolol—glaucoma	5.57e-05	0.000311	CcSEcCtD
Modafinil—Nausea—Clonidine—glaucoma	5.55e-05	0.00031	CcSEcCtD
Modafinil—ADRA1B—LPA receptor mediated events—MMP2—glaucoma	5.54e-05	0.0037	CbGpPWpGaD
Modafinil—Feeling abnormal—Timolol—glaucoma	5.48e-05	0.000306	CcSEcCtD
Modafinil—ADRA1B—GPCR ligand binding—PTGFR—glaucoma	5.48e-05	0.00366	CbGpPWpGaD
Modafinil—Gastrointestinal pain—Timolol—glaucoma	5.44e-05	0.000304	CcSEcCtD
Modafinil—Dizziness—Betaxolol—glaucoma	5.38e-05	0.000301	CcSEcCtD
Modafinil—SLC6A3—Neuronal System—SLC6A1—glaucoma	5.37e-05	0.00359	CbGpPWpGaD
Modafinil—Urticaria—Timolol—glaucoma	5.28e-05	0.000295	CcSEcCtD
Modafinil—Abdominal pain—Timolol—glaucoma	5.26e-05	0.000293	CcSEcCtD
Modafinil—Body temperature increased—Timolol—glaucoma	5.26e-05	0.000293	CcSEcCtD
Modafinil—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.25e-05	0.00351	CbGpPWpGaD
Modafinil—Vomiting—Betaxolol—glaucoma	5.17e-05	0.000289	CcSEcCtD
Modafinil—Rash—Betaxolol—glaucoma	5.13e-05	0.000287	CcSEcCtD
Modafinil—Dermatitis—Betaxolol—glaucoma	5.13e-05	0.000286	CcSEcCtD
Modafinil—Headache—Betaxolol—glaucoma	5.1e-05	0.000285	CcSEcCtD
Modafinil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.05e-05	0.00338	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—GSTM1—glaucoma	5e-05	0.00334	CbGpPWpGaD
Modafinil—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.98e-05	0.00333	CbGpPWpGaD
Modafinil—Hypersensitivity—Timolol—glaucoma	4.9e-05	0.000274	CcSEcCtD
Modafinil—Nausea—Betaxolol—glaucoma	4.83e-05	0.00027	CcSEcCtD
Modafinil—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	4.82e-05	0.00322	CbGpPWpGaD
Modafinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.79e-05	0.0032	CbGpPWpGaD
Modafinil—Asthenia—Timolol—glaucoma	4.77e-05	0.000266	CcSEcCtD
Modafinil—Pruritus—Timolol—glaucoma	4.7e-05	0.000263	CcSEcCtD
Modafinil—CYP1A2—Phase II conjugation—GSTT1—glaucoma	4.67e-05	0.00312	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—GSTT1—glaucoma	4.64e-05	0.0031	CbGpPWpGaD
Modafinil—Diarrhoea—Timolol—glaucoma	4.55e-05	0.000254	CcSEcCtD
Modafinil—CYP3A5—Biological oxidations—GSTT1—glaucoma	4.53e-05	0.00303	CbGpPWpGaD
Modafinil—Dizziness—Timolol—glaucoma	4.4e-05	0.000246	CcSEcCtD
Modafinil—Vomiting—Timolol—glaucoma	4.23e-05	0.000236	CcSEcCtD
Modafinil—Rash—Timolol—glaucoma	4.19e-05	0.000234	CcSEcCtD
Modafinil—Dermatitis—Timolol—glaucoma	4.19e-05	0.000234	CcSEcCtD
Modafinil—Headache—Timolol—glaucoma	4.16e-05	0.000233	CcSEcCtD
Modafinil—ADRA1B—LPA receptor mediated events—MMP9—glaucoma	4.16e-05	0.00278	CbGpPWpGaD
Modafinil—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.09e-05	0.00274	CbGpPWpGaD
Modafinil—Nausea—Timolol—glaucoma	3.95e-05	0.000221	CcSEcCtD
Modafinil—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.94e-05	0.00264	CbGpPWpGaD
Modafinil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.9e-05	0.00261	CbGpPWpGaD
Modafinil—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.85e-05	0.00257	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—CYP1B1—glaucoma	3.69e-05	0.00247	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	3.64e-05	0.00244	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—EDN1—glaucoma	3.61e-05	0.00241	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—CYP1B1—glaucoma	3.61e-05	0.00241	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	3.56e-05	0.00238	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—GSTT1—glaucoma	3.5e-05	0.00234	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—OPN4—glaucoma	3.44e-05	0.0023	CbGpPWpGaD
Modafinil—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	3.38e-05	0.00226	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CA5A—glaucoma	3.25e-05	0.00217	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NARFL—glaucoma	3.25e-05	0.00217	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.23e-05	0.00216	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.19e-05	0.00214	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NARFL—glaucoma	3.18e-05	0.00212	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CA5A—glaucoma	3.18e-05	0.00212	CbGpPWpGaD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.16e-05	0.00211	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—OPN4—glaucoma	3.12e-05	0.00209	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PTGFR—glaucoma	3.1e-05	0.00207	CbGpPWpGaD
Modafinil—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	3.08e-05	0.00206	CbGpPWpGaD
Modafinil—CYP1A2—Phase II conjugation—GSTM1—glaucoma	2.97e-05	0.00199	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—GSTM1—glaucoma	2.95e-05	0.00197	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	2.91e-05	0.00195	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.89e-05	0.00193	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—GSTM1—glaucoma	2.89e-05	0.00193	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	2.85e-05	0.0019	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	2.82e-05	0.00188	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PTGFR—glaucoma	2.81e-05	0.00188	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—CYP1B1—glaucoma	2.79e-05	0.00187	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—SMO—glaucoma	2.76e-05	0.00185	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	2.75e-05	0.00184	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GSTT1—glaucoma	2.73e-05	0.00183	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	2.67e-05	0.00178	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	2.67e-05	0.00178	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LRP12—glaucoma	2.66e-05	0.00178	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—TP53—glaucoma	2.66e-05	0.00178	CbGpPWpGaD
Modafinil—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	2.63e-05	0.00176	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.61e-05	0.00174	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—CYP1B1—glaucoma	2.55e-05	0.0017	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	2.51e-05	0.00168	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CA5A—glaucoma	2.46e-05	0.00164	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NARFL—glaucoma	2.46e-05	0.00164	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.39e-05	0.0016	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.38e-05	0.00159	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CA5A—glaucoma	2.24e-05	0.0015	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NARFL—glaucoma	2.24e-05	0.0015	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.23e-05	0.00149	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	2.22e-05	0.00148	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.2e-05	0.00147	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—CYP1B1—glaucoma	2.17e-05	0.00145	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	2.14e-05	0.00143	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.11e-05	0.00141	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.09e-05	0.0014	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.03e-05	0.00136	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.03e-05	0.00136	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.01e-05	0.00134	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CA5A—glaucoma	1.91e-05	0.00128	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NARFL—glaucoma	1.91e-05	0.00128	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	1.9e-05	0.00127	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	1.9e-05	0.00127	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—OPN4—glaucoma	1.84e-05	0.00123	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—EDN1—glaucoma	1.82e-05	0.00122	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GSTM1—glaucoma	1.74e-05	0.00116	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	1.71e-05	0.00115	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HEYL—glaucoma	1.71e-05	0.00115	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.68e-05	0.00112	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTGFR—glaucoma	1.66e-05	0.00111	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.66e-05	0.00111	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—C3—glaucoma	1.59e-05	0.00106	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CA1—glaucoma	1.59e-05	0.00106	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CA1—glaucoma	1.55e-05	0.00104	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CTSA—glaucoma	1.54e-05	0.00103	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CTSA—glaucoma	1.5e-05	0.001	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NARFL—glaucoma	1.48e-05	0.000987	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CA5A—glaucoma	1.48e-05	0.000987	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CA2—glaucoma	1.45e-05	0.000971	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CA2—glaucoma	1.42e-05	0.000949	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—SMO—glaucoma	1.42e-05	0.000948	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.34e-05	0.000897	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.32e-05	0.000885	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RPTOR—glaucoma	1.3e-05	0.000869	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NCK2—glaucoma	1.26e-05	0.000842	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CA1—glaucoma	1.2e-05	0.000802	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CTSA—glaucoma	1.16e-05	0.000777	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CA2—glaucoma	1.1e-05	0.000733	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CA1—glaucoma	1.09e-05	0.000731	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.07e-05	0.000717	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.07e-05	0.000717	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HDAC9—glaucoma	1.07e-05	0.000716	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CTSA—glaucoma	1.06e-05	0.000708	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—EDN1—glaucoma	1.03e-05	0.000688	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TXN—glaucoma	1.02e-05	0.000684	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CA2—glaucoma	1e-05	0.000669	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TXN—glaucoma	9.99e-06	0.000668	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.77e-06	0.000654	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.77e-06	0.000654	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EDN1—glaucoma	9.35e-06	0.000625	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CA1—glaucoma	9.34e-06	0.000625	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CTSA—glaucoma	9.05e-06	0.000605	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—C3—glaucoma	8.99e-06	0.000601	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CA2—glaucoma	8.54e-06	0.000571	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SMO—glaucoma	8.37e-06	0.00056	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.35e-06	0.000559	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.35e-06	0.000559	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—C3—glaucoma	8.16e-06	0.000546	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTT1—glaucoma	7.93e-06	0.00053	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTT1—glaucoma	7.75e-06	0.000518	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TXN—glaucoma	7.73e-06	0.000517	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NTRK2—glaucoma	7.66e-06	0.000512	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CA1—glaucoma	7.21e-06	0.000482	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.05e-06	0.000471	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TXN—glaucoma	7.05e-06	0.000471	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.99e-06	0.000467	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CTSA—glaucoma	6.98e-06	0.000467	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CA2—glaucoma	6.59e-06	0.000441	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NGFR—glaucoma	6.57e-06	0.000439	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.43e-06	0.00043	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.37e-06	0.000426	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCA1—glaucoma	6.32e-06	0.000422	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1B1—glaucoma	6.32e-06	0.000422	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NTRK1—glaucoma	6.24e-06	0.000418	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1B1—glaucoma	6.17e-06	0.000413	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCA1—glaucoma	6.17e-06	0.000413	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TXN—glaucoma	6.02e-06	0.000403	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTT1—glaucoma	5.99e-06	0.000401	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	5.75e-06	0.000385	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EDN1—glaucoma	5.52e-06	0.000369	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.49e-06	0.000367	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTT1—glaucoma	5.46e-06	0.000365	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.44e-06	0.000364	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NGF—glaucoma	5.07e-06	0.000339	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—glaucoma	5.05e-06	0.000338	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—glaucoma	4.94e-06	0.00033	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.83e-06	0.000323	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—C3—glaucoma	4.82e-06	0.000323	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCA1—glaucoma	4.77e-06	0.000319	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1B1—glaucoma	4.77e-06	0.000319	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTT1—glaucoma	4.67e-06	0.000312	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TXN—glaucoma	4.65e-06	0.000311	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOE—glaucoma	4.49e-06	0.0003	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—glaucoma	4.46e-06	0.000298	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CAV1—glaucoma	4.45e-06	0.000298	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.4e-06	0.000295	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—glaucoma	4.36e-06	0.000292	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1B1—glaucoma	4.35e-06	0.000291	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCA1—glaucoma	4.35e-06	0.000291	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FN1—glaucoma	4.23e-06	0.000283	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BAD—glaucoma	4.18e-06	0.00028	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOE—glaucoma	4.15e-06	0.000278	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAV1—glaucoma	4.12e-06	0.000275	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOE—glaucoma	4.06e-06	0.000272	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAV1—glaucoma	4.02e-06	0.000269	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—glaucoma	3.82e-06	0.000255	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.76e-06	0.000252	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1B1—glaucoma	3.72e-06	0.000249	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCA1—glaucoma	3.72e-06	0.000249	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTT1—glaucoma	3.6e-06	0.000241	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—glaucoma	3.48e-06	0.000233	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—glaucoma	3.37e-06	0.000226	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOS3—glaucoma	3.36e-06	0.000225	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOE—glaucoma	3.14e-06	0.00021	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NOS3—glaucoma	3.11e-06	0.000208	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAV1—glaucoma	3.11e-06	0.000208	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—glaucoma	3.08e-06	0.000206	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NOS3—glaucoma	3.04e-06	0.000203	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—glaucoma	2.97e-06	0.000199	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	2.91e-06	0.000195	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1B1—glaucoma	2.87e-06	0.000192	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCA1—glaucoma	2.87e-06	0.000192	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOE—glaucoma	2.86e-06	0.000191	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—glaucoma	2.85e-06	0.00019	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAV1—glaucoma	2.84e-06	0.00019	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—glaucoma	2.78e-06	0.000186	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—glaucoma	2.7e-06	0.00018	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—glaucoma	2.63e-06	0.000176	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOE—glaucoma	2.45e-06	0.000164	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAV1—glaucoma	2.42e-06	0.000162	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—glaucoma	2.42e-06	0.000162	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NOS3—glaucoma	2.35e-06	0.000157	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—glaucoma	2.29e-06	0.000153	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—glaucoma	2.15e-06	0.000144	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NOS3—glaucoma	2.14e-06	0.000143	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—glaucoma	2.03e-06	0.000136	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—glaucoma	1.96e-06	0.000131	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOE—glaucoma	1.89e-06	0.000126	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAV1—glaucoma	1.87e-06	0.000125	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NOS3—glaucoma	1.83e-06	0.000123	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—glaucoma	1.83e-06	0.000122	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—glaucoma	1.68e-06	0.000112	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NOS3—glaucoma	1.41e-06	9.46e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—glaucoma	1.29e-06	8.65e-05	CbGpPWpGaD
